Definium Therapeutics, Inc. (DFTX)
Market Closed
1 Sep, 20:00
$
38. 50
-1.22
-3.0715%
$
5.27B Market Cap
- P/E Ratio
- Div Yield
1.57M Volume
- Eps
$ 39.72
Previous Close 
Want to track DFTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Definium Therapeutics, Inc. (DFTX) Statistics
Valuation metrics
Market Cap 5.27B
Enterprise value 4.82B
Trailing P/E (ttm) -11.91
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) -
Price/Book (mrq) 4.94
Enterprise Value/Revenue -
Enterprise Value/EBITDA -14.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.8M
Average volume (90 days) 3.25M
Price summary
52-Week low 8.7
52-Week high 49.7
Beta -
50-Day moving average 44.8
200-Day moving average 23.65
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.32%
Return on equity -0.85%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.79
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 6.95%
Book value per share (mrq) 8.3
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
